RB

Robert Bob Brookins

Dr Brookins has more than 15 years of experience in organic synthesis and materials chemistry. Dr Brookins led the development and commercialisation of Alexium's phase change material (PCM) platform technologies and the AlexiCool product line, which is the foundation of the Company's success in the bedding and top-of-bed markets. He is a member of the Risk Committee.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
AJX
AJX
30/06/2410,696,346N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
AJX
AJX
20/12/24
Issued
25,067,138$0.011$275,738Issue of securities
AJX
AJX
23/09/24
Cancelled
6,871,445$0.010$68,714Cancellation of securities
AJX
AJX
03/05/24
Issued
3,850,000$0.013$50,050Placement
AJX
AJX
12/01/24
Issued
6,505,703$0.014$91,079Issue of securities
AJX
AJX
31/03/23
Issued
13,377,148$0.020$267,542Issue of securities